PLOS one publication
Stemina Biomarker Discovery, Inc. today announced the publication of research conducted in collaboration with the MIND Institute at the University of California-Davis to identify biomarkers in the blood of children with autism spectrum disorders (ASD) that can distinguish them from typically developing children. The research is the first of its kind and has the potential to enable earlier diagnosis and treatment of children with ASD from a blood sample.
- Studies have consistently shown that earlier diagnosis of #autism spectrum disorder helps kids achieve better outco… https://t.co/63zYtqetpC17 hours ago
- Eye-tracking technology helped researchers at the University of Kent gauge the reactions of adults with #autism to… https://t.co/OagWfJuLLpyesterday
- MRIs can be stressful for anyone, and they’re especially hard for patients with autism spectrum disorder. Researche… https://t.co/QyvEd0bvKT2 days ago